1,459
Views
38
CrossRef citations to date
0
Altmetric
Research Letter

Rapidly increasing prescribing of proton pump inhibitors in primary care despite interventions: A nationwide observational study

, , , , , & show all
Pages 290-293 | Received 14 Jun 2013, Accepted 18 Feb 2014, Published online: 29 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Rami B. Tarabay, Mona H. Osman, Riwa S. Aridi, Sani A. Hlais, Ranin Y. Beshara & Najla A. Lakkis. (2022) The effect of a patient informative leaflet on chronic use of proton pump inhibitors in a primary care center: a randomized control trial. Hospital Practice 50:4, pages 318-325.
Read now
Peter Fentz Haastrup, Jane Møller Hansen, Jens Søndergaard & Dorte Ejg Jarbøl. (2021) Proton pump inhibitor use among patients at risk of peptic ulcer bleeding: a nationwide register-based study. Scandinavian Journal of Gastroenterology 56:1, pages 6-12.
Read now
Jonas Sanberg Ljungdalh, Katrine Hass Rubin, Jesper Durup & Kim Christian Houlind. (2019) Treatment of newly-diagnosed gastroesophageal reflux disease: a nationwide register-based cohort study. Scandinavian Journal of Gastroenterology 54:7, pages 830-837.
Read now

Articles from other publishers (35)

Humphrey J. O'Connor. (2023) Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy . Helicobacter 28:6.
Crossref
Lu Liu, Yongqi Yu, Qingze Fan, Zhigui Wu, Xiuying Li & Hongli Luo. (2022) Impact of proton pump inhibitor management committee’s multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments. BMC Health Services Research 22:1.
Crossref
Eric Lespessailles & Hechmi Toumi. (2022) Proton Pump Inhibitors and Bone Health: An Update Narrative Review. International Journal of Molecular Sciences 23:18, pages 10733.
Crossref
Renata Rodriguez Imparato & Tereza Setsuko Toma. (2022) Proton pump inhibitor deprescription: A rapid review. Brazilian Journal of Pharmaceutical Sciences 58.
Crossref
Amy Trang, Jordan Bushman & Alexandra Halalau. (2021) Effect of Long-Term Proton Pump Inhibitor Use on Glycemic Control in Patients with Type Two Diabetes Mellitus. Journal of Diabetes Research 2021, pages 1-4.
Crossref
Jonas Sanberg Ljungdalh, Katrine Hass Rubin, Jesper Durup & Kim Christian Houlind. (2020) Trends of anti-reflux surgery in Denmark 2000–2017: a nationwide registry-based cohort study. Surgical Endoscopy 35:7, pages 3662-3669.
Crossref
Malin Inghammar, Henrik Svanström, Marianne Voldstedlund, Mads Melbye, Anders Hviid, Kåre Mølbak & Björn Pasternak. (2021) Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection . Clinical Infectious Diseases 72:12, pages e1084-e1089.
Crossref
Rita Baptista, Ryane Englar, Berta São Braz & Rodolfo Leal. (2021) Survey-Based Analysis of Current Trends for Prescribing Gastrointestinal Protectants among Small-Animal General Practitioners in Portugal. Veterinary Sciences 8:5, pages 70.
Crossref
Leander Muheim, Andri Signorell, Stefan Markun, Corinne Chmiel, Stefan Neuner-Jehle, Eva Blozik, Pascale Ursprung, Thomas Rosemann & Oliver Senn. (2021) Potentially inappropriate proton-pump inhibitor prescription in the general population: a claims-based retrospective time trend analysis. Therapeutic Advances in Gastroenterology 14, pages 175628482199892.
Crossref
Paulo Pimentel Assumpção, Williams Fernandes Barra, Geraldo Ishak, Luiz Gonzaga Vaz Coelho, Felipe José Fernandez Coimbra, Helano Carioca Freitas, Emmanuel Dias-Neto, M. Constanza Camargo & Moyses Szklo. (2020) The diffuse-type gastric cancer epidemiology enigma. BMC Gastroenterology 20:1.
Crossref
Jianping Xiong, Yaqin Wang, Guang Chen & Long Jin. (2020) Proton pump inhibitors and the risk of gallbladder cancer: a hospital-based case–control study. Gut 69:12, pages 2265-2267.
Crossref
Jianping Xiong, Yaqin Wang, Weiyu Xu, Zhisong Liu, Haochen Wang, Zhiyuan Zhang, Yanjing Han, Chao Yin, Shasha Cao, Zheran Yang, Tianhao Su, Jian Wei, Guang Chen & Long Jin. (2020) Proton pump inhibitors and odds of cholangiocarcinoma: A retrospective case‐control study. Liver International 40:11, pages 2848-2857.
Crossref
Atif H. Alzahrani, Punitha Arasaratnam, Samia Massalha, Ali Alenazy, Alex Lee, Owen Clarkin, Robert A deKemp, Alomgir Hossain, Rob S. Beanlands, Terrence D. Ruddy & Benjamin J. W. Chow. (2019) Effect of proton pump inhibitors on Rubidium-82 gastric uptake using positron emission tomography myocardial perfusion imaging. Journal of Nuclear Cardiology 27:5, pages 1443-1451.
Crossref
Sanne Rasmussen, Cecilie Thit Jensen, Marianne Rosendal, Henrik Bjarke Vægter, Jens Søndergaard & Dorte Ejg Jarbøl. (2020) Multiple physical symptoms and individual characteristics – A cross-sectional study of the general population. Journal of Psychosomatic Research 131, pages 109941.
Crossref
Jonas Sanberg Ljungdalh, Katrine Hass Rubin, Jesper Durup & Kim Christian Houlind. (2020) Long-term patient satisfaction and durability of laparoscopic anti-reflux surgery in a large Danish cohort: study protocol for a retrospective cohort study with development of a novel scoring system for patient selection. BMJ Open 10:3, pages e034257.
Crossref
Christian Labenz, Karel Kostev, Peter R. Galle, Marcus-Alexander Wörns, Joachim Labenz, Christian Tanislav & Charles Christian Adarkwah. (2020) Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis. Medicine 99:50, pages e23436.
Crossref
Dorte E Jarbøl, Jesper Lykkegaard, Jane M Hansen, Anders Munck & Peter F Haastrup. (2019) Prescribing of proton-pump inhibitors: auditing the management and reasons for prescribing in Danish general practice. Family Practice 36:6, pages 758-764.
Crossref
Ignacio Aznar‐Lou, Mette Reilev, Anders Bergh Lødrup, Maria Rubio‐Valera, Peter Fentz Haastrup & Anton Pottegård. (2019) Use of proton pump inhibitors among Danish children: A 16‐year register‐based nationwide study. Basic & Clinical Pharmacology & Toxicology 124:6, pages 704-710.
Crossref
Bryony Porter, Antony Arthur & George M Savva. (2019) How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study. BMJ Open 9:5, pages e026171.
Crossref
Peter Fentz Haastrup, Wade Thompson, Jens Søndergaard & Dorte Ejg Jarbøl. (2018) Side Effects of Long-Term Proton Pump Inhibitor Use: A Review. Basic & Clinical Pharmacology & Toxicology 123:2, pages 114-121.
Crossref
Williams Fernandes Barra, Samia Demachki, Geraldo Ishak & Paulo Pimentel de Assumpção. 2018. Diffuse Gastric Cancer. Diffuse Gastric Cancer 5 14 .
Mona Boudabous, Héla Gdoura, Leila Mnif, Lassad Chtourou, Amal Grati, Ali Amouri & Nabil Tahri. 2017. Esophageal Abnormalities. Esophageal Abnormalities.
Berit E.S. Jensen, Jane M. Hansen, Kasper S. Larsen, Anders B. Junker, Jens F. Lassen, Svend E. Jensen & Ove B. Schaffalitzky de Muckadell. (2017) Randomized clinical trial. European Journal of Gastroenterology & Hepatology 29:10, pages 1118-1125.
Crossref
Devendra Pratap Singh, Swapnil P. Borse & Manish Nivsarkar. (2017) Overcoming the exacerbating effects of ranitidine on NSAID-induced small intestinal toxicity with quercetin: Providing a complete GI solution. Chemico-Biological Interactions 272, pages 53-64.
Crossref
Jonas Sanberg Jensen, Henning Kold Antonsen & Jesper Durup. (2017) Two years of experience with robot-assisted anti-reflux surgery: A retrospective cohort study. International Journal of Surgery 39, pages 260-266.
Crossref
Cesare Tosetti & Ilaria Nanni. (2017) Use of proton pump inhibitors in general practice. World Journal of Gastrointestinal Pharmacology and Therapeutics 8:3, pages 180.
Crossref
Devendra Pratap Singh, Swapnil P. Borse & Manish Nivsarkar. (2017) Co-administration of quercetin with pantoprazole sodium prevents NSAID-induced severe gastroenteropathic damage efficiently: Evidence from a preclinical study in rats. Experimental and Toxicologic Pathology 69:1, pages 17-26.
Crossref
Jens Van Den Abeele, Jari Rubbens, Joachim Brouwers & Patrick Augustijns. (2017) The dynamic gastric environment and its impact on drug and formulation behaviour. European Journal of Pharmaceutical Sciences 96, pages 207-231.
Crossref
P. F. Haastrup, S. Rasmussen, J. M. Hansen, R. D. Christensen, J. Søndergaard & D. E. Jarbøl. (2016) General practice variation when initiating long-term prescribing of proton pump inhibitors: a nationwide cohort study. BMC Family Practice 17:1.
Crossref
Anton Pottegård, Anne Broe, Jesper Hallas, Ove B. Schaffalitzky de Muckadell, Annmarie T. Lassen & Anders B. Lødrup. (2016) Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study. Therapeutic Advances in Gastroenterology 9:5, pages 671-678.
Crossref
Devendra Pratap Singh, Swapnil P. Borse & Manish Nivsarkar. (2016) Clinical importance of nonsteroidal anti-inflammatory drug enteropathy: the relevance of tumor necrosis factor as a promising target. Translational Research 175, pages 76-91.
Crossref
P. F. Haastrup, M. S. Paulsen, R. D. Christensen, J. Søndergaard, J. M. Hansen & D. E. Jarbøl. (2016) Medical and non-medical predictors of initiating long-term use of proton pump inhibitors: a nationwide cohort study of first-time users during a 10-year period. Alimentary Pharmacology & Therapeutics 44:1, pages 78-87.
Crossref
Bjarne Nesgaard Andersen, Per Birger Johansen & Bo Abrahamsen. (2016) Proton pump inhibitors and osteoporosis. Current Opinion in Rheumatology 28:4, pages 420-425.
Crossref
Jon Eik Zwisler, Dorte Ejg Jarbøl, Annmarie Touborg Lassen, Jakob Kragstrup, Niels Thorsgaard & Ove B. Schaffalitzky de Muckadell. (2015) Placebo-Controlled Discontinuation of Long-Term Acid-Suppressant Therapy: A Randomised Trial in General Practice. International Journal of Family Medicine 2015, pages 1-7.
Crossref
Wojciech Marlicz, Igor Łoniewski, David S. Grimes & Eamonn M. Quigley. (2014) Nonsteroidal Anti-inflammatory Drugs, Proton Pump Inhibitors, and Gastrointestinal Injury: Contrasting Interactions in the Stomach and Small Intestine. Mayo Clinic Proceedings 89:12, pages 1699-1709.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.